Works matching IS 2160763X AND DT 2021 AND VI 10 AND IP 6

Results: 13

A Phase 1 Study to Investigate the Effects of Cortexolone 17α‐Propionate, Also Known as Clascoterone, on the QT Interval Using the Meal Effect to Demonstrate ECG Assay Sensitivity.

Published in:

Clinical Pharmacology in Drug Development, 2021, v. 10, n. 6, p. 572, doi. 10.1002/cpdd.935

By:

Täubel, Jörg;
Mazzetti, Alessandro;
Ferber, Georg;
Burch, William;
Fernandes, Sara;
Patel, Avani;
Spencer, Christopher S.;
Freier, Anne;
Graff, Claus;
Kanters, Jørgen K.;
Camm, John

Publication type:

Article

Evaluation of the CYP3A and CYP2B6 Drug‐Drug Interaction Potential of Lemborexant.

Published in:

Clinical Pharmacology in Drug Development, 2021, v. 10, n. 6, p. 681, doi. 10.1002/cpdd.915

By:

Landry, Ishani;
Aluri, Jagadeesh;
Nakai, Kenya;
Hall, Nancy;
Miyajima, Yukiko;
Ueno, Takashi;
Dayal, Satish;
Filippov, Gleb;
Lalovic, Bojan;
Moline, Margaret;
Reyderman, Larisa

Publication type:

Article

Pharmacokinetics of Gepotidacin in Subjects With Normal Hepatic Function and Hepatic Impairment.

Published in:

Clinical Pharmacology in Drug Development, 2021, v. 10, n. 6, p. 588, doi. 10.1002/cpdd.913

By:

Hossain, Mohammad;
Tiffany, Courtney;
Tao, Yu;
Barth, Aline;
Marbury, Thomas C.;
Preston, Richard A.;
Dumont, Etienne

Publication type:

Article

Safety, Pharmacokinetics, and Pharmacodynamics of a Dipeptidyl Peptidase‐4 Inhibitor: A Randomized, Double‐Blinded, Placebo‐Controlled Daily Administration of Fotagliptin Benzoate for 14 Days for Type 2 Diabetes Mellitus.

Published in:

Clinical Pharmacology in Drug Development, 2021, v. 10, n. 6, p. 660, doi. 10.1002/cpdd.895

By:

Wu, Min;
Li, Qian‐Qian;
Zhang, Hong;
Zhu, Xiao‐Xue;
Li, Xiao‐Jiao;
Li, Ying;
Sun, Hai‐Gang;
Ding, Yan‐Hua

Publication type:

Article

Issue Information.

Published in:: Clinical Pharmacology in Drug Development, 2021, v. 10, n. 6, p. 567, doi. 10.1002/cpdd.713
Publication type:: Article

Phase 1 Study of the Effects of the Tuberculosis Treatment Pretomanid, Alone and in Combination With Moxifloxacin, on the QTc Interval in Healthy Volunteers.

Published in:

Clinical Pharmacology in Drug Development, 2021, v. 10, n. 6, p. 634, doi. 10.1002/cpdd.898

By:

Li, Mengchun;
Saviolakis, George A.;
El‐Amin, Wael;
Makhene, Mamodikoe K.;
Osborn, Blaire;
Nedelman, Jerry;
Yang, Tian J.;
Everitt, Daniel

Publication type:

Article

Safety, Tolerability, and Pharmacokinetics of Tazarotene Clindamycin Cream: A Single‐Dose, 3‐Period Crossover Study.

Published in:

Clinical Pharmacology in Drug Development, 2021, v. 10, n. 6, p. 598, doi. 10.1002/cpdd.890

By:

Li, Lei;
Zhang, Xing‐fei;
Yang, Guo‐ping;
Huang, Jie;
Yang, Xiao‐yan;
Ye, Ling;
Guo, Can;
Yang, Shuang;
Wang, Xiao‐min

Publication type:

Article

Pharmacokinetics of Belimumab in Children With Systemic Lupus Erythematosus.

Published in:

Clinical Pharmacology in Drug Development, 2021, v. 10, n. 6, p. 622, doi. 10.1002/cpdd.889

By:

Dimelow, Richard;
Ji, Beulah;
Struemper, Herbert

Publication type:

Article

Pharmacokinetics of Deutetrabenazine and Tetrabenazine: Dose Proportionality and Food Effect.

Published in:

Clinical Pharmacology in Drug Development, 2021, v. 10, n. 6, p. 647, doi. 10.1002/cpdd.882

By:

Schneider, Frank;
Stamler, David;
Bradbury, Margaret;
Loupe, Pippa S.;
Hellriegel, Edward;
Cox, Donna S.;
Savola, Juha‐Matti;
Gordon, Mark Forrest;
Rabinovich‐Guilatt, Laura

Publication type:

Article

A Phase 1 Dose‐Escalation Study of Low‐Dose Metronomic Treatment With Novel Oral Paclitaxel Formulations in Combination With Ritonavir in Patients With Advanced Solid Tumors.

Published in:

Clinical Pharmacology in Drug Development, 2021, v. 10, n. 6, p. 607, doi. 10.1002/cpdd.880

By:

Weger, Vincent A.;
Vermunt, Marit A.C.;
Stuurman, Frederik E.;
Burylo, Artur M.;
Damoiseaux, David;
Hendrikx, Jeroen J.M.A.;
Sawicki, Emilia;
Moes, Johannes J.;
Huitema, Alwin D.R.;
Nuijen, Bastiaan;
Rosing, Hilde;
Mergui‐Roelvink, Marja;
Beijnen, Jos H.;
Marchetti, Serena

Publication type:

Article

Pharmacokinetics of Ginsenoside Rh2, the Major Anticancer Ingredient of Ginsenoside H Dripping Pills, in Healthy Subjects.

Published in:

Clinical Pharmacology in Drug Development, 2021, v. 10, n. 6, p. 669, doi. 10.1002/cpdd.877

By:

Wang, Zhenlei;
Liu, Rui;
Chen, Li;
Wang, Huanhuan;
Zhou, Mi;
Wang, Yongsheng;
Qin, Yongping

Publication type:

Article

Bioequivalence and Evaluation Parameters Based on the Pharmacodynamics of Miglitol in Healthy Volunteers.

Published in:

Clinical Pharmacology in Drug Development, 2021, v. 10, n. 6, p. 582, doi. 10.1002/cpdd.873

By:

Yan, Juan;
Li, Xiao‐Min;
Zhang, Yan‐Xin;
Xu, Su‐Mei;
Liu, Wan‐Li;
Guo, Jie;
Hu, Xiao‐Lei;
Zou, Ting;
Xu, Yu‐Ying;
Xu, Ping‐Sheng

Publication type:

Article

Effect of Food Intake on the Pharmacokinetics of the Selective Progesterone Receptor Modulator Vilaprisan: A Randomized Clinical Study in Healthy Postmenopausal Women.

Published in:

Clinical Pharmacology in Drug Development, 2021, v. 10, n. 6, p. 675, doi. 10.1002/cpdd.876

By:

Schultze‐Mosgau, Marcus‐Hillert;
Kaiser, Andreas;
Zollmann, Frank S.

Publication type:

Article